Total Payments
$8,021
2024 Payments
$1,222
Companies
42
Transactions
240
Medicare Patients
5,766
Medicare Billing
$1.0M
Payment Breakdown by Category
Food & Beverage$5,759 (71.8%)
Travel$2,158 (26.9%)
Education$104.32 (1.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,759 | 221 | 71.8% |
| Travel and Lodging | $2,158 | 13 | 26.9% |
| Education | $104.32 | 6 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $2,008 | 35 | $0 (2024) |
| Abbott Laboratories | $1,674 | 54 | $0 (2024) |
| Relievant Medsystems, Inc. | $1,092 | 11 | $0 (2023) |
| Collegium Pharmaceutical, Inc. | $684.25 | 43 | $0 (2024) |
| Nevro Corp. | $538.25 | 9 | $0 (2024) |
| Saluda Medical Americas, Inc. | $288.51 | 3 | $0 (2024) |
| Forte Bio-Pharma LLC | $208.62 | 9 | $0 (2024) |
| Stryker Corporation | $172.01 | 1 | $0 (2024) |
| PFIZER INC. | $142.99 | 9 | $0 (2021) |
| Stimwave Technologies Incorporated | $104.32 | 6 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,222 | 36 | Saluda Medical Americas, Inc. ($288.51) |
| 2023 | $1,047 | 35 | Relievant Medsystems, Inc. ($580.17) |
| 2022 | $1,674 | 39 | Relievant Medsystems, Inc. ($511.62) |
| 2021 | $853.18 | 55 | BOSTON SCIENTIFIC CORPORATION ($170.69) |
| 2020 | $1,498 | 29 | Boston Scientific Corporation ($1,154) |
| 2019 | $1,488 | 41 | Abbott Laboratories ($1,011) |
| 2018 | $238.57 | 5 | Abbott Laboratories ($183.30) |
All Payment Transactions
240 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | BIOTRONIK NRO, Inc. | Prospera (Device) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: Not Applicable | ||||||
| 11/25/2024 | Saluda Medical Americas, Inc. | Evoke (Device) | Food and Beverage | In-kind items and services | $23.93 | General |
| Category: Spinal Cord Stimulator | ||||||
| 11/19/2024 | BIOTRONIK NRO, Inc. | Prospera (Device) | Food and Beverage | In-kind items and services | $25.63 | General |
| Category: Not Applicable | ||||||
| 11/14/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $24.34 | General |
| Category: Opioid Analgesic | ||||||
| 11/12/2024 | Forte Bio-Pharma LLC | NALOCET (Drug), PROLATE, PROLATE | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: PAIN | ||||||
| 11/06/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $20.65 | General |
| Category: Opioid Analgesic | ||||||
| 10/24/2024 | Stryker Corporation | MILD DEVICE KIT (Device) | Food and Beverage | In-kind items and services | $172.01 | General |
| Category: INSTRUMENTS | ||||||
| 10/22/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 10/08/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $24.30 | General |
| Category: Spinal Cord Stimulator | ||||||
| 09/23/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $20.65 | General |
| Category: Opioid Analgesic | ||||||
| 09/19/2024 | Forte Bio-Pharma LLC | NALOCET (Drug), PROLATE, PROLATE | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: PAIN | ||||||
| 09/17/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $16.66 | General |
| Category: Opioid Analgesic | ||||||
| 09/17/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $16.66 | General |
| Category: Opioid Analgesic | ||||||
| 08/08/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $25.04 | General |
| Category: Spinal Cord Stimulator | ||||||
| 07/11/2024 | Forte Bio-Pharma LLC | NALOCET (Drug), PROLATE, PROLATE | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: PAIN | ||||||
| 07/09/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $17.57 | General |
| Category: Opioid Analgesic | ||||||
| 07/02/2024 | BIOTRONIK NRO, Inc. | Prospera (Device) | Food and Beverage | In-kind items and services | $26.76 | General |
| Category: Not Applicable | ||||||
| 06/04/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: General - Pain Management_NMD | ||||||
| 05/23/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $4.24 | General |
| Category: Opioid Analgesic | ||||||
| 05/22/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: General - Pain Management_NMD | ||||||
| 05/21/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: General - Pain Management_NMD | ||||||
| 05/20/2024 | Vertos Medical, Inc. | mild Device Kit (Device) | Food and Beverage | In-kind items and services | $51.81 | General |
| Category: Orthopedic | ||||||
| 05/16/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $26.42 | General |
| Category: General - Pain Management_NMD | ||||||
| 05/14/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $14.50 | General |
| Category: Opioid Analgesic | ||||||
| 05/09/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $29.29 | General |
| Category: Neuromodulation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 1,473 | 3,243 | $1.2M | $288,584 |
| 2022 | 19 | 1,261 | 2,580 | $906,181 | $233,968 |
| 2021 | 23 | 1,674 | 3,192 | $1.6M | $310,657 |
| 2020 | 24 | 1,358 | 2,121 | $934,311 | $179,582 |
Total Patients
5,766
Total Services
11,136
Medicare Billing
$1.0M
Procedure Codes
90
All Medicare Procedures & Services
90 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 232 | 592 | $232,296 | $57,102 | 24.6% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 103 | 277 | $164,672 | $53,774 | 32.7% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 188 | 547 | $103,673 | $33,242 | 32.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 235 | 501 | $138,978 | $32,480 | 23.4% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 85 | 370 | $70,790 | $17,758 | 25.1% |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 46 | 113 | $53,110 | $17,341 | 32.7% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2023 | 81 | 117 | $83,717 | $12,822 | 15.3% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 46 | 67 | $57,422 | $10,928 | 19.0% |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 69 | 95 | $34,217 | $10,591 | 31.0% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Facility | 2023 | 54 | 84 | $40,913 | $6,633 | 16.2% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2023 | 36 | 61 | $48,169 | $6,292 | 13.1% |
| 64633 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 16 | 23 | $19,872 | $3,841 | 19.3% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Facility | 2023 | 41 | 75 | $18,249 | $3,802 | 20.8% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Facility | 2023 | 36 | 61 | $27,754 | $3,663 | 13.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 39 | 39 | $13,158 | $3,425 | 26.0% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Facility | 2023 | 15 | 26 | $22,773 | $3,077 | 13.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 22 | 22 | $11,548 | $2,934 | 25.4% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Facility | 2023 | 25 | 27 | $9,202 | $2,142 | 23.3% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Facility | 2023 | 37 | 48 | $8,769 | $1,951 | 22.2% |
| 64634 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | Facility | 2023 | 15 | 26 | $7,422 | $1,501 | 20.2% |
| 64491 | Injection of upper or middle spine facet joint using imaging guidance, second level | Facility | 2023 | 12 | 20 | $9,581 | $1,381 | 14.4% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 22 | 33 | $4,776 | $1,256 | 26.3% |
| 96136 | Administration of psychological or neuropsychological test, first 30 minutes | Office | 2023 | 18 | 19 | $1,444 | $650.37 | 45.0% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 112 | 255 | $152,875 | $50,059 | 32.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 220 | 437 | $172,271 | $41,626 | 24.2% |
About David Neckman
David Neckman is a Anesthesiology healthcare provider based in Conyers, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/19/2013. The National Provider Identifier (NPI) number assigned to this provider is 1801138615.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, David Neckman has received a total of $8,021 in payments from pharmaceutical and medical device companies, with $1,222 received in 2024. These payments were reported across 240 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($5,759).
As a Medicare-enrolled provider, Neckman has provided services to 5,766 Medicare beneficiaries, totaling 11,136 services with total Medicare billing of $1.0M. Data is available for 4 years (2020–2023), covering 90 distinct procedure/service records.
Ad
Practice Information
- Specialty Anesthesiology
- Other Specialties Pain Medicine, Interventional Pain Medicine
- Location Conyers, GA
- Active Since 03/19/2013
- Last Updated 04/09/2021
- Taxonomy Code 207L00000X
- Entity Type Individual
- NPI Number 1801138615
Products in Payments
- SUPERION (Device) $1,114
- Intracept (Device) $1,092
- Proclaim Family of SCS IPGs (Device) $772.71
- XTAMPZA (Drug) $504.74
- Protege Family of SCS IPGs (Device) $485.43
- Omnia (Device) $471.66
- Evoke (Device) $288.51
- WaveWriter Alpha Prime 16 (Device) $219.98
- PROCLAIM (Device) $213.42
- Belbuca (Drug) $179.51
- MILD DEVICE KIT (Device) $172.01
- Proclaim IPG (Device) $147.44
- NALOCET (Drug) $125.72
- GENERAL PAIN MANAGEMENT (Device) $124.32
- StimQ Receiver Stimulator Kit Channel A US w Receiver (Device) $104.32
- General - Pain Management (Device) $97.24
- Prospera (Device) $86.80
- LYRICA (Drug) $85.78
- Superion Indirect Decompression System (Device) $77.02
- Zilretta (Drug) $73.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anesthesiology Doctors in Conyers
Sadik Haba, M.d, M.D
Anesthesiology — Payments: $916.61
Anesthesiology $916.61
Selwynn Howard, M.d, M.D
Anesthesiology — Payments: $119.13
Anesthesiology $119.13
James Vinson, M.d, M.D
Anesthesiology — Payments: $83.27
Anesthesiology $83.27
Kimball Patton, M.d, M.D
Anesthesiology — Payments: $53.03
Anesthesiology $53.03
Dr. Trent Tadsen, Md, MD
Anesthesiology
Anesthesiology
Dinah Franklin, M.d, M.D
Anesthesiology
Anesthesiology